NASDAQ:IART

Integra Lifesciences Holdings Stock News

etoro logo Buy IART
*Your capital is at risk
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Bio-Rad (BIO) launches a blood-based immunoassay kit to better detect antibodies in response to SARS-CoV-2 infection.
Man Group plc cut its stake in Integra Lifesciences Holdings Corp (NASDAQ:IART) by 24.2% in the 4th quarter, Holdings Channel reports. The firm owned 32,800 shares of the life sciences company’s sto
Integra (IART) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Integra (IART) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Integra (IART) unable to measure the magnitude of total loss it has to bear out of the coronavirus-led economic damages, and hence, withdraws the full-year guidance.
Integra (IART) unable to measure the magnitude of total loss it has to bear out of the coronavirus-led economic damages, and hence, withdraws the full-year guidance.
Geode Capital Management LLC lifted its stake in shares of Integra Lifesciences Holdings Corp (NASDAQ:IART) by 1.6% during the fourth quarter, according to its most recent disclosure with the Securiti
The rising in the animal population, new product launches, and strategic collaboration, are key factors contributing to the high CAGR of the Veterinary Electrosurgery market during the forecast period
Alliancebernstein L.P. increased its holdings in Integra Lifesciences Holdings Corp (NASDAQ:IART) by 3.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. T
The global advanced wound care market size is expected to reach USD 9.3 billion by 2027, expanding at a CAGR of 5.2% over the forecast period, according to a new report by Grand View Research, Inc. Ri
Integra Lifesciences (NASDAQ:IART) had its target price decreased by research analysts at Wells Fargo & Co from $62.00 to $46.00 in a research report issued on Monday, BenzingaRatingsTable reports. Th
Integra Lifesciences (NASDAQ:IART)‘s stock had its “hold” rating reaffirmed by equities researchers at Piper Sandler in a report released on Tuesday, TipRanks reports. They presently have a $58.
BTIG analyst Ryan Zimmerman maintained a Buy rating on Integra Lifesciences (IART) yesterday and set a price target of $59.00. The company's shares closed
BTIG analyst Ryan Zimmerman maintained a Buy rating on Integra Lifesciences (IART – Research Report) yesterday and set a price
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE